Kymera Therapeutics, Inc. (KYMR)
KYMR price $112.63 -0.83 -0.73%
- Ticker
- KYMR
- Price
- $112.63
- Change
- -0.83 -0.73%
- Market cap
- $9.26B
- P/E
- -34.91
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 48
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various…